Sindhiya Jan
Director, Global Clinical Development - Early and Late Stage Vaccines & Immune Therapies @AstraZeneca
Signup · Get unlimited contacts
WORK HISTORY
Director, Global Clinical Development - Early and Late Stage Vaccines & Immune Therapies @AstraZeneca
Cambridge, GB
Global Clinical Development Lead for Beyfortus (Nirsevimab - RSV) and Hepatitis B program
EDUCATION
University of Geneva
ADVAC - Advanced Course of Vaccinology, Annecy
Università di Siena
Postgraduate Diploma in Clinical Research, Clinical Research
Liaquat University of Medical and Health Sciences
Doctor of Dental Surgery, Dentistry
Harvard Kennedy School
Executive Education, Public leadership
London School of Hygiene and Tropical Medicine, U. of London
Training, Real World Evidence in Pharmacoepidemiology
Duke University
Executive Women in Leadership Program & Mini MBA, Organizational Leadership and Business Management
University of Washington
Training, Infectious Disease and Epidemiology
ECPM / European Center of Pharmaceutical Medicine
Diploma Advance studies in Pharmaceutical Medicine. In-person
London School of Hygiene and Tropical Medicine, U. of London
Training, Epidemiology
Università di Siena
MSc/Masters in Vaccinology and Pharmaceutical Clinical Development - Full time
SKILLS
ABOUT SINDHIYA JAN
I am an accomplished and results-driven Clinical Development and Global Medical Affairs Expert with over a decade of experience advancing innovative therapeutic programs. My career spans top-tier pharmaceutical companies, including GSK and AstraZeneca, and renowned hospitals. I have successfully advanced high-impact assets from early-phase development to late-phase trials, securing regulatory approvals across major markets, including the U.S, EU, and Asia.With expertise in end-to-end trial execution, I lead cross-functional teams in the design and delivery of innovative clinical trials from Phase 1 to Phase 3 pivotal trials, including regulatory submissions and post-approval strategies. In addition, I bring extensive global medical affairs experience with experience in Early & Late vaccines, and LCM assets, providing scientific leadership in launch readiness, real-world evidence (RWE) integration, and KOL and advisory board management. Passionate about translating scientific advancements into real-world patient impact, I am committed to advancing global health outcomes through the successful delivery of high-impact clinical programs.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.